This enhancement was achieved by downregulating the mRNA and protein levels of P-gp and ABCG2, demonstrated in both in vitro and in vivo models of CRC using HCT8 and SW480 cells (Zhang et al., 2018). Here, ABCG2 is linked to colorectal carcinoma.